Insider trade

Director received an award of 5,127 EW shares

Traded May 8, 2026 · Filed May 9, 2026

Edwards LifesciencesEW

5,127
Shares

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: May 8, 2026
Reporting period: Not applicable
Filed with the SEC: May 9, 2026

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001225208-26-005055
Filed / recorded

May 9, 2026, 1:18 AM UTC

Added to OQRO

Oct 2, 2026, 12:27 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

Edwards Lifesciences Corp

Issuer CIK

1099800

Ticker

EW

Reporting person

Nicholas J Valeriani

Relationship

Director

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

May 8, 2026

Transaction code

A

Shares / units

5,127

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

84,423

Ownership form

Direct

Amendment

No

Footnotes from the filing

These restricted stock units were granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.